newsfilter
← Interviews
All-In Podcast1h 28m

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

Sam Altman, Elon, Lina Khan, Chamath, David Friedberg, David Sacks

The All In podcast team debuted a new segment reading negative listener feedback from r/allin, where hosts faced harsh characterizations as wealthy elites or incompetent workers while also announcing their 2023 summit sold out. The group then analyzed Sam Altman's Senate testimony as a strategic regulatory moat to protect OpenAI against open-source competitors, though they noted that decentralized AI development makes centralized licensing impractical. Finally, the hosts discussed the collapsing San Francisco commercial real estate market, the FTC's anti-trust block on the Amgen-Horizon merger, and the diverging market reactions to Apple's new $3,000 AR headset.